Ascertain

Name: Ascertain
Brand: Ascertain

AI Native

Agentic AI for healthcare operations. Ascertain what matters, automate the rest.

Est 2022|Valuation $35M|Raised $17.4M

LinkedIn 3K|Web traffic 3K|FTEs 60|HQ New York, New York, US

01Competitive Landscape

Narrative analysis

Ascertain vs Notable: Both vendors present agent-style automation and payer portal work automation. Notable provides a productized authorizations solution and a broader suite; Ascertain positions itself as an adaptable automation layer with human oversight and audit logs.
Ascertain vs Waystar: Waystar is a larger RCM platform with authorization automation features. Ascertain, a small vendor by headcount, may be more flexible for custom workflows but carries vendor concentration and integration risk.
Ascertain vs CoverMyMeds: CoverMyMeds has substantial adoption for medication ePA and a different pricing model; Ascertain targets broader administrative workflows beyond medication prior auth.

- Ascertain vs Notable: Both vendors present agent-style automation and payer portal work automation. Notable provides a productized authorizations solution and a broader suite; Ascertain positions itself as an adaptable automation layer with human oversight and audit logs. - Ascertain vs Waystar: Waystar is a larger RCM platform with authorization automation features. Ascertain, a small vendor by headcount, may be more flexible for custom workflows but carries vendor concentration and integration risk. - Ascertain vs CoverMyMeds: CoverMyMeds has substantial adoption for medication ePA and a different pricing model; Ascertain targets broader administrative workflows beyond medication prior auth.

	Ascertain	Notable	Waystar
Starting Price	Not publicly listed	Not publicly listed	Not publicly listed
Primary target	Health systems/providers/payers seeking administrative workflow automation with human oversight and audit logs	Provider organizations seeking agent-style automation and no-code workflow tooling across access and RCM	Organizations focused on RCM/payments seeking authorization automation within a broader payments platform
Key strengths	Broad advertised workflow scope; emphasis on traceability and human oversight; public references to strategic partnerships	Productized authorizations module; broader patient access and engagement capabilities	Large RCM platform footprint and integrated payments capabilities
Key weaknesses	Limited third-party reviews; security certifications not clearly public; enterprise-only pricing model not published	Platform complexity and enterprise integration requirements; claims are vendor-reported	May be optimized for RCM/payment workflows rather than bespoke automation outside supported flows

Ascertain

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map